Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct-Dec;22(4):274-281.
doi: 10.18502/jri.v22i4.7653.

Comparison of Tamoxifen and Clomiphene Citrate for Ovulation Induction in Women with Polycystic Ovarian Syndrome: A Prospective Study

Sangita Sharma  1 , Manisha Choudhary  1 , Vikas Swarankar  1 , Vaibhav Vaishnav  2
Affiliations

Comparison of Tamoxifen and Clomiphene Citrate for Ovulation Induction in Women with Polycystic Ovarian Syndrome: A Prospective Study

Sangita Sharma et al. J Reprod Infertil. 2021 Oct-Dec.

Abstract

Background: The purpose of this study was to compare the efficacy of tamoxifen and clomiphene citrate in induction of ovulation in women with PCOS and anovulation.

Methods: In this prospective cohort study, 104 women with PCOS and primary infertility were enrolled after fulfilling the inclusion and exclusion criteria. The patients were allocated in two groups; group A (n=54) received tamoxifen 40 mg once daily (Days 3-7) and group B (n=50) received clomiphene citrate 100 mg once daily (Days 3-7). Serial ultrasounds were done till the administration of human chorionic gonadotropin (hCG). The ovulation and pregnancy rates in both groups were compared. The number of dominant follicles, estradiol levels, and endometrial thickness were also studied. Comparison was done using chi-square and student's t-test and a p-value of less than 0.05 was considered statistically significant.

Results: The number of dominant follicles and serum estradiol levels were significantly higher in group B (p<0.05), whereas the endometrial thickness was significantly more in group A (p<0.05). The ovulation rates were similar in both groups (66.6% vs. 70%, p=0.715). Pregnancy rate per treatment cycle and per ovulatory cycle was marginally higher in group A (14.81% and 22.22%, respectively), as compared to group B (14% and 20%, respectively), but the difference was not statistically significant (p>0.05).

Conclusion: Tamoxifen and clomiphene citrate are both equally effective in induction of ovulation and achieving a pregnancy in women with PCOS.

Keywords: Anovulation; Clomiphene; Infertility; Ovulation induction; Polycystic ovary syndrome; Pregnancy rates; Tamoxifen.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest There is no conflict of interest to disclose.

Figures

Figure 1.
Figure 1.
The study flow diagram
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with poor pregnancy outcome in women with polycystic ovary syndrome. Br J Obstet Gynaecol. 1999;99(2): 128–31. - PubMed
    1. Berek JS. Novak's textbook of gynecology. 13th ed. US: Williams & Wilkins; 2002. 1432 p.
    1. NICE guidelines. Fertility problems: assessment and treatment (CG156); 2013. 51 p.
    1. Greenblatt RB, Barfield WE, Jungck EC, Ray AW. Induction of ovulation with MRL/41, preliminary report. JAMA. 1961;178:101–4. - PubMed
    1. Wolf LJ. Ovulation induction. Clin Obstet Gynecol. 2000;43(4):902–15. - PubMed

LinkOut - more resources